SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGT ((VSE:IGT) Blockbuster Anti-Cancer Test Results !!!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: coach137 who wrote (8)7/3/1997 6:01:00 PM
From: Bruce A. Anderson   of 94
 
It could be anything but one possibility relates to the drug Etoposide for which IGT announced successful patenting June 23. In that press release, the company advised that it was in initial discussions for licensing or partnering Etoposide techology with a major generic drug company. The market may be starting to take note of this development and also the upcoming clinical trials for Anhydrodvinblastine. I noticed that much of the trading today was by way of buyers taking out the offers and the closing offer was 1.14 with only 1600 shares available at that price. Looking good.....ba/
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext